← Back to Search

ReCharge for Diabetes (ChargeUp Trial)

N/A
Waitlist Available
Led By Anna Kahkoska, MD, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults 30 years and older
Type 1 diabetes OR latent autoimmune diabetes in adults (LADA) clinically managed as type 1 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 and 36 weeks
Awards & highlights

ChargeUp Trial Summary

This study is designed to compare two behavioral approaches to reduce diabetes distress ("the expected burdens, concerns, fears, and threats that arise from the challenges of living with diabetes") in adults with type 1 diabetes. At the study baseline, participants will be randomized to take part in one of two virtual, group-based interventions (the "Primary" intervention) utilizing either an emotions-focused or a problem-solving approach to reduce diabetes distress. After the initial intervention, participants will complete surveys to assess their response to the material. Participants who are determined to be "non-responders" (i.e., the Primary intervention was not effective) will be re-randomized to one of two "Supplementary" interventions, which will include individualized sessions to learn and/or practice strategies related to either the psychological or problem-solving approach.

Eligible Conditions
  • Diabetes
  • Type 1 Diabetes
  • Emotional Distress

ChargeUp Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ChargeUp Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 and 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Total Diabetes Distress (T1-DDS Total Score)
Secondary outcome measures
Change in Core Diabetes Distress (T1-DDAS Core Score)
Change in Diabetes Quality of Life
Change in Diabetes Specific Self-Compassion
+9 more
Other outcome measures
Intervention Satisfaction
Long-term Change in Core Diabetes Distress (T1-DDAS Core Score)
Long-term Change in Hemoglobin A1c (HbA1c)
+7 more

ChargeUp Trial Design

2Treatment groups
Experimental Treatment
Group I: TakeChargeExperimental Treatment1 Intervention
Participants randomized to TakeCharge will participate in a problem-solving focused intervention facilitated by a diabetes care professional.
Group II: ReChargeExperimental Treatment1 Intervention
Participants randomized to ReCharge will participate in an emotions-focused intervention facilitated by a mental health professional.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,512 Previous Clinical Trials
4,194,173 Total Patients Enrolled
8 Trials studying Diabetes
2,161 Patients Enrolled for Diabetes
American Diabetes AssociationOTHER
140 Previous Clinical Trials
99,606 Total Patients Enrolled
17 Trials studying Diabetes
1,867 Patients Enrolled for Diabetes
Anna Kahkoska, MD, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~133 spots leftby Sep 2027